Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 32253074)

Published in Eur J Surg Oncol on March 28, 2020

Authors

Yun Shin Chun1, Takashi Mizuno2, Jordan M Cloyd3, Min Jin Ha4, Kiyohiko Omichi2, Ching-Wei D Tzeng2, Thomas A Aloia2, Naoto T Ueno5, Henry M Kuerer6, Carlos H Barcenas5, Jean-Nicolas Vauthey2

Author Affiliations

1: Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: yschun@mdanderson.org.
2: Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
3: Department of Surgery, Ohio State University, Columbus, OH, USA.
4: Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
5: Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
6: Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Articles by these authors

RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol (2016) 0.86

Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients. Ann Surg Oncol (2015) 0.81

Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment. J Hepatol (2016) 0.80

Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. HPB (Oxford) (2013) 0.77

Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy. Ann Surg Oncol (2015) 0.77

Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction. Ann Surg Oncol (2016) 0.76

Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments? Hepatobiliary Surg Nutr (2017) 0.75

Re "Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections". HPB (Oxford) (2016) 0.75

Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. HPB (Oxford) (2017) 0.75

Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases. Ann Surg Oncol (2017) 0.75

Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status. J Cancer (2017) 0.75

Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy. Ann Surg Oncol (2015) 0.75

Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection. J Gastrointest Surg (2016) 0.75

Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases. Ann Surg Oncol (2017) 0.75

Tips and tricks of splenic vessel preservation during laparoscopic distal pancreatectomy. Surg Endosc (2017) 0.75

Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members. Ann Surg Oncol (2017) 0.75

Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter? Ann Surg Oncol (2017) 0.75

The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology. Ann Surg Oncol (2016) 0.75

Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol (2017) 0.75

Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Ann Surg Oncol (2016) 0.75

Portal Vein Embolization: Tailoring, Optimizing, and Quantifying an Invaluable Procedure in Hepatic Surgery. Ann Surg Oncol (2017) 0.75

Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater. Ann Surg Oncol (2017) 0.75

Laparoscopic Glissonean Pedicle Transection (Takasaki) for Negative Fluorescent Counterstaining of Segment 6. Ann Surg Oncol (2016) 0.75

Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection. Ann Surg Oncol (2017) 0.75

Effective Laparoscopic Management Lymph Node Dissection for Gallbladder Cancer. Ann Surg Oncol (2017) 0.75

AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. Surg Oncol (2021) 0.75

Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma. Ann Surg Oncol (2017) 0.75

Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low-Incidence Countries. Ann Surg Oncol (2017) 0.75

Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma. Surg Oncol (2021) 0.75

Laparoscopic Management of Gallbladder Cancer: A Stepwise Approach. Ann Surg Oncol (2016) 0.75

Local Therapy for Colorectal Liver Metastases: Establishing Today's Level of Evidence and Defining Tomorrow's Roadmap. J Natl Cancer Inst (2017) 0.75

Inflammation and pro-resolution inflammation after hepatobiliary surgery. World J Surg Oncol (2017) 0.75